FAK has been shown to be overexpressed in various types of cancer, including GBM20, 21, 22, and to modulate actin polymerization and lamellipodial protrusion23, suggesting that FAK is a potential target for anti-invasive therapies for various cancers. This evidence concerns the gene PTK2 and cancer.